Heterogeneity of cell therapy products
S. Afr. med. j. (Online)
;
109(8): 25-29, 2019. ilus
Artículo
en Inglés
| AIM
| ID: biblio-1271225
ABSTRACT
Cellular therapy has become a billion-dollar industry and is set to become one of the therapeutic pillars of healthcare in the 21st century. Adult stem cells, which include haematopoietic stem and progenitor cells (HSPCs) and mesenchymal stromal/stem cells (MSCs), is one of the major cell types currently under investigation for use in cell therapy. This review focuses on HSPCs and MSCs and discusses their heterogeneous nature and the problems faced in expanding these cells to therapeutic numbers for use in clinical applications
Buscar en Google
Índice:
AIM (África)
Asunto principal:
Terapéutica
/
Productos del Gen gag
/
Células
/
Heterogeneidad Genética
Idioma:
Inglés
Revista:
S. Afr. med. j. (Online)
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS